NCT03236493View on ClinicalTrials.gov

Safety and Pharmacokinetic Study of PF-06700841 in Japanese Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

August 16, 2017

Primary Completion Date

September 17, 2017

Study Completion Date

October 12, 2017

Conditions
Healthy
Interventions
DRUG

PF-06700841

PF-06700841 will be administered as tablet

DRUG

Placebo

Matching placebo will be administered as tablet

Trial Locations (1)

B-1070

Pfizer Clinical Research Unit, Brussels

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT03236493 - Safety and Pharmacokinetic Study of PF-06700841 in Japanese Healthy Volunteers | Biotech Hunter | Biotech Hunter